Annexin A2 mediates anti-β2GPI/β 2GPI-induced tissue factor expression on monocytes

International Journal of Molecular Medicine

Volumn 24, Issue 4, 2009, Pages 557-562

  Zhou, Hong ^a   Wang, Haibo ^a   Li, Na ^a   Yu, Ying ^b   Huang, Hongliang ^a   Yan, Yihong ^a   Wang, Ting ^a  

^a JIANGSU UNIVERSITY   (China)

^b Zhejiang Hospital of Traditional Chinese Medicine   (China)

Author keywords

2 glycoprotein I; Annexin A2; Anti 2 glycoprotein I antibodies; Monocyte; Tissue factor

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; COMPLEMENTARY DNA; LIPOCORTIN 2; MESSENGER RNA; THROMBOPLASTIN;

ARTICLE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

ANNEXIN A2; ANTIGEN-ANTIBODY COMPLEX; BETA 2-GLYCOPROTEIN I; CELL LINE; GENE EXPRESSION; HUMANS; MONOCYTES; THROMBOPLASTIN;

EID: 70350786142     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000265     Document Type: Article

References (29)

1. McNeil HP, Chesterman CN and Krilis S: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49: 193-280, 1991.
2. De Groot PG and Derksen RH: Antiphospholipid antibodies. Update on detection, pathophysiology and treatment. Curr Opin Haematol 11: 165-169, 2004.
3. Miyakis S, Lockshin MD, Atsumi T, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306, 2006.
4. Galli M and Barbui T: Antiphospholipid antibodies and thrombosis: strength of association. Hematol J 4: 180-186, 2003.
5. Giannakopoulos B, Passam F, Ioannou Y and Krilis SA: How we diagnose the antiphospholipid syndrome. Blood 113: 985-994, 2009.
6. Kinev AV and Roubey RAS: Tissue factor in the antiphospholipid syndrome. Lupus 17: 953-959, 2008.
7. Nojima J, Masuda Y, Iwatani Y, et al: Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem Biophys Res Commun 365: 195-200, 2008.
8. Morrissey JH: Tissue factor: an enzyme cofactor and true receptor. Thromb Haemost 86: 66-74, 2001.
9. Khajuria A and Houston DS: Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood 96: 966-972, 2000.
10. Steinemann S, Ulevitch RJ and Mackman N: Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb Vasc Biol 14: 1202-1209, 1994.
11. Zhou H, Wolberg AS and Roubey RAS: Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 104: 2353-2358, 2004.
12. Zhou H: Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. Acta Pharma Sinica 25: 1366-1371, 2004.
13. Wolberg AS and Roubey RAS: Mechanisms of autoantibody-induced monocyte tissue factor expression. Thromb Res 114: 391-396, 2004.
14. Gerke V and Moss SE: Annexins: From structure to function. Physiol Rev 82: 331-371, 2002.
15. 2-glycoprotein 1 antibodies. Blood 105: 1964-1969, 2005.
16. 2GPI-induced tissue factor expression on monocytes. Cell Res 17: 737-739, 2007.
17. De Groot PG and Derksen RH: Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 3: 1854-1860, 2005.
18. Giannakopoulos B, Passam F, Rahgozar S and Krilis SA: Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109: 422-430, 2007.
19. 2-glycoprotein I with phosphatidylserine containing membranes: ligand dependent conformational alterations initiate bivalent binding. Biochemistry 46: 10612-10620, 2007.
20. 2-glycoprotein I complexes with lipid vesicles in macrophages: Implications on the development of antiphospholipid syndrome. J Autoimmun 29: 164-173, 2007.
21. 2-glycorotein I only after a conformational change. Blood 107: 1916-1924, 2006.
22. 2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J Lipid Res 42: 697-709, 2001.
23. 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J Biol Chem 278: 33831-33838, 2003.
24. Moss SE and Morgan RO: The annexins. Genome Biol 5: 219, 2004.
25. Falcone DJ, Birth W, Khan KMF and Hajjar KA: Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97: 777-784, 2001.
26. Urbanus RT, Derksen RH and de Groot PG: Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev 22: 93-105, 2008.
27. Raschi E, Borghi MO, Grossi C, Broggini V, Pierangeli S and Meroni PL: Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 17: 937-942, 2008.
28. Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151, 2008.
29. Raschi E, Testoni C, Bosisio D, et al: Role of the MyD88 transduction signaling pathway in endothelial activation by phospholipids antibodies. Blood 101: 3495-3500, 2003.